Indeed, anti-transglutaminase levels were lower in CI than in CeD patients, but patients with CI nevertheless presented significantly higher anti-transglutaminase IgA levels than HC, whereas the differences in anti-transglutaminase IgG were close to the limit of significance. Here, CD79A is linked to cranioectodermal dysplasia.